Article
Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.
British journal of clinical pharmacology - 1 Jun 2013
Voon Pei Jye, Yap Hui Ling, Ma Cho-Yee-Thu, Lu Fan, Wong Andrea L A, Sapari Nur Sabrina, Soong Richie, Soh Thomas I P, Goh Boon-Cher, Lee How-Sung, Lee Soo-Chin
Abstract excerpt
AIMS: Aldo-ketoreductases have been implicated in the metabolism of doxorubicin. We sought to assess the influence of AKR1C3 genetic variants on doxorubicin metabolism. METHODS: We sequenced AKR1C3 exon 5 and genotyped seven functional single nucleotide polymorphisms in CBR3, ABCB1 and SLC22A16 involved in doxorubicin pharmacology in 151 Asian breast cancer patients treated with doxorubicin-containing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
